Atea Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $863.6M
Liabilities Breakdown FY2020
Total Liabilities: $315.8M
Asset Breakdown
Total Assets: $863.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $850.1M | 98.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $48.0K | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $13.5M | 1.6% |
Liabilities Breakdown
Total Liabilities: $315.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $60.0K | 0.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $315.8M | 100.0% |